Literature DB >> 8988077

Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.

T Siegal1, R Rubinstein, T Tzuk-Shina, J M Gomori.   

Abstract

It was recently demonstrated that imaging of brain tumors by relative cerebral blood volume (CBV) maps reconstructed from dynamic magnetic resonance (MR) data provide similar diagnostic information compared to positron emission tomography (PET) or 201Tl single-photon emission computerized tomography (201Tl-SPECT) scans. The authors used relative CBV mapping for routine follow-up evaluation of patients with brain tumors and compared its sensitivity to diagnostic MR imaging, 201Tl-SPECT and clinical assessment. Fifty-nine patients were prospectively followed using 191 concomitant studies of dual section relative CBV maps, MR imaging, 201Tl-SPECT, and neurological evaluations. Studies were repeated every 2 to 3 months (median three evaluations/patient). The relative CBV maps were graded as relative CBV 0 to 4, where Grades 3 and 4 are indicative of proliferating tumors (four = rapid leak). There were 44 high-grade and 15 low-grade tumors followed during treatment. During the follow-up period a change in relative CBV grade was observed in 56% of the patients, revealing an increasing grade in 72% of them. The rapid leak phenomenon was detected in 35% of all studies and in 81% of those with a worsening relative CBV grade. Tumor progression was detected earlier by relative CBV maps as follows: earlier than MR imaging in 32% of the studies (earlier by a median of 4.5 months; p < 0.01); earlier than 201Tl-SPECT in 63% (median 4.5 months; p < 0.01), and earlier than clinical assessment in 55% (median 6 months; p < 0.01). In 82% of studies with positive MR imaging but negative 201Tl-SPECT, the lesions were smaller than 1.5 cm. The relative CBV maps clearly delineated the appearance of rapid leak in these lesions. Routine use of relative CBV maps that can be implemented on any high-field MR unit and added to the regular MR evaluation provides useful functional information in patients with brain tumors. When used as an adjunct follow-up evaluation it proved more sensitive than the other modalities for early prediction of tumor growth. It is very sensitive to small regional changes, unlike functional imaging such as PET or SPECT scans. Based on previous experience with 76 regional CBV studies, the authors conclude that regional CBV mapping correlates with active tumor and it may separate enhancing scar and radiation injury from infiltrative tumor. A new effect named the rapid leak phenomenon was also observed; this phenomenon, as identified on the regional CBV maps, correlates with high malignancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988077     DOI: 10.3171/jns.1997.86.1.0022

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

Review 1.  Advances in the assessment of childhood brain tumors and treatment-related sequelae.

Authors:  Katherine E Warren
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

2.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Authors:  Eric S Paulson; Kathleen M Schmainda
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

3.  High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle.

Authors:  Csanad G Varallyay; Eric Nesbit; Rongwei Fu; Seymur Gahramanov; Brendan Moloney; Eric Earl; Leslie L Muldoon; Xin Li; William D Rooney; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-13       Impact factor: 6.200

4.  Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.

Authors:  Alan Jackson; Andrea Kassner; Deborah Annesley-Williams; Helen Reid; Xiau-Ping Zhu; Kah-Loh Li
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 5.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 6.  Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.

Authors:  Michelle M Kim; Theodore S Lawrence; Yue Cao
Journal:  Semin Radiat Oncol       Date:  2015-02-21       Impact factor: 5.934

7.  Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.

Authors:  Kathleen M Schmainda; Scott D Rand; Allen M Joseph; Rebecca Lund; B Doug Ward; Arvind P Pathak; John L Ulmer; Michael A Badruddoja; Michael A Baddrudoja; Hendrikus G J Krouwer
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

8.  Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.

Authors:  Keith R Thulborn; Aiming Lu; Ian C Atkinson; Mohan Pauliah; Kathryn Beal; Timothy A Chan; Antonio Omuro; Josh Yamada; Michelle S Bradbury
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

9.  Role of perfusion CT in glioma grading and comparison with conventional MR imaging features.

Authors:  S K Ellika; R Jain; S C Patel; L Scarpace; L R Schultz; J P Rock; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

10.  Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors.

Authors:  Sung Ki Cho; Dong Gyu Na; Jae Wook Ryoo; Hong Gee Roh; Chan Hong Moon; Hong Sik Byun; Jong Hyun Kim
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.